<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35099338</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1365-2060</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>54</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Annals of medicine</Title>
          <ISOAbbreviation>Ann Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China.</ArticleTitle>
        <Pagination>
          <StartPage>442</StartPage>
          <EndPage>453</EndPage>
          <MedlinePgn>442-453</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/07853890.2022.2031273</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aimed to develop a nomogram to predict risk of resistance to intravenous immunoglobulin (IVIG) in children with Kawasaki disease in eastern China.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively analysed the data of children with Kawasaki disease who received IVIG during hospitalisation at Soochow University Affiliated Children's Hospital. IVIG resistance was defined as recrudescent or persistent fever ≥36 h after the end of the IVIG infusion. Baseline variables were analysed using least absolute shrinkage and selection operator (LASSO) to identify the predictors of IVIG resistance, which were then used to construct a predictive nomogram. Calibration curve and area under the receiver operating characteristic curve (AUC) were used to evaluate the performance of the model. The predictive nomogram was validated on test sets of external data and prospective data.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Between January 2015 and December 2020, 1293 Kawasaki disease patients were hospitalized in Soochow University Affiliated Children's Hospital. Among them, 72 (5.57%) showed IVIG resistance. LASSO identified haemoglobin, percentage of neutrophils, C-reactive protein level, platelet count, serum albumin, serum sodium, serum alkaline phosphatase, coronary artery damage, and complete Kawasaki disease as risk factors for IVIG resistance. The nomogram constructed using these factors showed satisfactory discriminatory power (AUC, 0.75), and sensitivity (0.74) and specificity (0.64). In the external data and prospective data, the AUC was 0.66 and 0.83, respectively, the sensitivity was 0.86 and 1, respectively, and the specificity was 0.49 and 0.60, respectively.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The predictive nomogram constructed using nine factors associated with IVIG resistance in children with Kawasaki disease could be a useful tool for identifying patients likely to show IVIG resistance. This nomogram may help reduce the risk of coronary artery lesions.Key MessagesNone of the IVIG resistance scoring systems has shown consistently good performance in previous studies. Tools to predict the risk of IVIG resistance in eastern China are lacking.In our series, haemoglobin level, percentage of neutrophils, platelet count, coronary artery damage, incomplete Kawasaki disease, and CRP, serum albumin, serum sodium, and serum alkaline phosphatase levels were risk factors of IVIG resistance in hospitalized children in the eastern China cities of Suzhou and Fuzhou.We propose an easy-to-use nomogram to predict the risk factors of IVIG resistance in hospitalized children.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Hongbiao</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Fujian Provincial Hospital, Fujian Provincial Clinical College of Fujian Medical University, Fuzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Jiaqi</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shi</LastName>
            <ForeName>Xiaosong</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Fujian Provincial Hospital, Fujian Provincial Clinical College of Fujian Medical University, Fuzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qin</LastName>
            <ForeName>Jie</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dong</LastName>
            <ForeName>Jinfeng</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology and Rheumatology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Lei</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Chengcheng</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Ying</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zheng</LastName>
            <ForeName>Yiming</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hou</LastName>
            <ForeName>Miao</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shen</LastName>
            <ForeName>Qin</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zeng</LastName>
            <ForeName>Bihe</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qian</LastName>
            <ForeName>Guanghui</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Fang</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Fujian Provincial Hospital, Fujian Provincial Clinical College of Fujian Medical University, Fuzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lv</LastName>
            <ForeName>Haitao</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Ann Med</MedlineTA>
        <NlmUniqueID>8906388</NlmUniqueID>
        <ISSNLinking>0785-3890</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016756" MajorTopicYN="Y">Immunoglobulins, Intravenous</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009080" MajorTopicYN="Y">Mucocutaneous Lymph Node Syndrome</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049451" MajorTopicYN="N">Nomograms</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Kawasaki disease</Keyword>
        <Keyword MajorTopicYN="Y">LASSO regression</Keyword>
        <Keyword MajorTopicYN="Y">intravenous immunoglobulin resistance</Keyword>
        <Keyword MajorTopicYN="Y">nomogram</Keyword>
        <Keyword MajorTopicYN="Y">prediction model</Keyword>
      </KeywordList>
      <CoiStatement>None of the authors declare any competing interest related to this study.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>31</Day>
          <Hour>12</Hour>
          <Minute>14</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35099338</ArticleId>
        <ArticleId IdType="pmc">PMC8812733</ArticleId>
        <ArticleId IdType="doi">10.1080/07853890.2022.2031273</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Lo MS, Newburger JW.. 
Role of intravenous immunoglobulin in the treatment of Kawasaki disease. Int J Rheum Dis. 2018;21(1):64–69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29205910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogata S, Bando Y, Kimura S, et al. . 
The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. J Cardiol. 2009;53(1):15–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19167633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang H, Xu L, Ding Y, et al. . 
Bioinformatics identification of hub genes and signaling pathways regulated by intravenous immunoglobulin treatment in acute Kawasaki disease. Exp Ther Med. 2021;22(1):1–13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8145699</ArticleId>
            <ArticleId IdType="pubmed">34055083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Group J.
Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease. Pediatr Int. 2005;47(6):711–732.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16354233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wright DA, Newburger JW, Baker A, et al. . 
Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr. 1996;128(1):146–149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8551407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ae R, Abrams JY, Maddox RA, et al. . 
Corticosteroids added to initial intravenous immunoglobulin treatment for the prevention of coronary artery abnormalities in high-risk patients with Kawasaki disease. J Am Heart Assoc. 2020;9(17):e015308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7660775</ArticleId>
            <ArticleId IdType="pubmed">32811256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobayashi T, Inoue Y, Takeuchi K, et al. . 
Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113(22):2606–2612.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16735679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Egami K, Muta H, Ishii M, et al. . 
Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr. 2006;149(2):237–240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16887442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sano T, Kurotobi S, Matsuzaki K, et al. . 
Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr. 2006;166(2):131–137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16896641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sleeper LA, Minich LL, McCrindle BM, Pediatric Heart Network Investigators, et al.. 
Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011;158(5):831–835.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3075321</ArticleId>
            <ArticleId IdType="pubmed">21168857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Son MBF, Gauvreau K, Kim S, et al. . 
Predicting coronary artery aneurysms in Kawasaki disease at a North American center: an assessment of baseline z scores. JAHA. 2017;6(6):e005378.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5669166</ArticleId>
            <ArticleId IdType="pubmed">28566299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang Y, Yan W, Sun L, et al. . 
Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an east China population. Clin Rheumatol. 2016;35(11):2771–2776.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27491972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Newburger JW, Takahashi M, Gerber MA, et al. . 
Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young. American Heart Association. Circulation. 2004;110(17):2747–2771.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15505111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCrindle BW, Rowley AH, Newburger JW, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention, et al.. 
Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American heart association. Circulation. 2017;135(17):e927–e99.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28356445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akagi T, Rose V, Benson LN, et al. . 
Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr. 1992;121(5):689–694.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1432415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedman J, Hastie T, Tibshirani R.. 
Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2929880</ArticleId>
            <ArticleId IdType="pubmed">20808728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H, Zhang L, Liu Z, et al. . 
Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram. Patient Prefer Adherence. 2018;12:1757–1765. Volume</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6136915</ArticleId>
            <ArticleId IdType="pubmed">30237698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu J, Qiu J, Xie E, et al. . 
Predicting in-hospital rupture of type a aortic dissection using random Forest. J Thorac Dis. 2019;11(11):4634–4646.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6940214</ArticleId>
            <ArticleId IdType="pubmed">31903252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kliegman RM, Stanton BM, Geme JS. Growth, development, and behavior. Nelson textbook of pediatrics. 20th ed. Elsevier; 2015. p. 52.</Citation>
        </Reference>
        <Reference>
          <Citation>Okada K, Hara J, Maki I, Osaka Kawasaki Disease Study Group, et al.. 
Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease. Eur J Pediatr. 2009;168(2):181–185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18446365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang S, Song R, Zhang J, et al. . 
Predictive tool for intravenous immunoglobulin resistance of Kawasaki disease in Beijing. Arch Dis Child. 2019;104(3):262–267.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30026252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie T, Wang Y, Fu S, et al. . 
Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease. Pediatr Rheumatol. 2017;15(1):17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5359815</ArticleId>
            <ArticleId IdType="pubmed">28320400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei M, Huang M, Chen S, et al. . 
A multicenter study of intravenous immunoglobulin non-response in Kawasaki disease. Pediatr Cardiol. 2015;36(6):1166–1172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25812827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma K, Vignesh P, Srivastava P, et al. . 
Epigenetics in Kawasaki disease. Front Pediatr. 2021;9:673294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8266996</ArticleId>
            <ArticleId IdType="pubmed">34249810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuan P, Su D, Mandal KD, et al. . 
Outcomes of Kawasaki disease with giant coronary aneurysms: a single-Centre study in southwest China. Cardiol Young. 2020;30(6):834–839.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32508295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, et al. . 
Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease. Paediatr Int Child Health. 2018;38(3):209–212.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29768976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ashouri N, Takahashi M, Dorey F, et al. . 
Risk factors for nonresponse to therapy in Kawasaki disease. J Pediatr. 2008;153(3):365–368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18534243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rigante D, Valentini P, Rizzo D, et al. . 
Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome. Rheumatol Int. 2010;30(6):841–846.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20049445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sato S, Kawashima H, Kashiwagi Y, et al. . 
Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients. Int J Rheum Dis. 2013;16(2):168–172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23773640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hua W, Sun Y, Wang Y, et al. . 
A new model to predict intravenous immunoglobin-resistant Kawasaki disease. Oncotarget. 2017;8(46):80722–80729.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5655234</ArticleId>
            <ArticleId IdType="pubmed">29113339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lalles JP.
Recent advances in intestinal alkaline phosphatase, inflammation, and nutrition. Nutr Rev. 2019;77(10):710–724.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31086953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peters E, Geraci S, Heemskerk S, et al. . 
Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate. Br J Pharmacol. 2015;172(20):4932–4945.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4621995</ArticleId>
            <ArticleId IdType="pubmed">26222228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang T, Liu G, Lin H.. 
A machine learning approach to predict intravenous immunoglobulin resistance in kawasaki disease patients: a study based on a southeast China population. PLoS One. 2020;15(8):e0237321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7451628</ArticleId>
            <ArticleId IdType="pubmed">32853226</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35099338</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1365-2060</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>54</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Annals of medicine</Title>
          <ISOAbbreviation>Ann Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China.</ArticleTitle>
        <Pagination>
          <StartPage>442</StartPage>
          <EndPage>453</EndPage>
          <MedlinePgn>442-453</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/07853890.2022.2031273</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aimed to develop a nomogram to predict risk of resistance to intravenous immunoglobulin (IVIG) in children with Kawasaki disease in eastern China.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively analysed the data of children with Kawasaki disease who received IVIG during hospitalisation at Soochow University Affiliated Children's Hospital. IVIG resistance was defined as recrudescent or persistent fever ≥36 h after the end of the IVIG infusion. Baseline variables were analysed using least absolute shrinkage and selection operator (LASSO) to identify the predictors of IVIG resistance, which were then used to construct a predictive nomogram. Calibration curve and area under the receiver operating characteristic curve (AUC) were used to evaluate the performance of the model. The predictive nomogram was validated on test sets of external data and prospective data.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Between January 2015 and December 2020, 1293 Kawasaki disease patients were hospitalized in Soochow University Affiliated Children's Hospital. Among them, 72 (5.57%) showed IVIG resistance. LASSO identified haemoglobin, percentage of neutrophils, C-reactive protein level, platelet count, serum albumin, serum sodium, serum alkaline phosphatase, coronary artery damage, and complete Kawasaki disease as risk factors for IVIG resistance. The nomogram constructed using these factors showed satisfactory discriminatory power (AUC, 0.75), and sensitivity (0.74) and specificity (0.64). In the external data and prospective data, the AUC was 0.66 and 0.83, respectively, the sensitivity was 0.86 and 1, respectively, and the specificity was 0.49 and 0.60, respectively.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The predictive nomogram constructed using nine factors associated with IVIG resistance in children with Kawasaki disease could be a useful tool for identifying patients likely to show IVIG resistance. This nomogram may help reduce the risk of coronary artery lesions.Key MessagesNone of the IVIG resistance scoring systems has shown consistently good performance in previous studies. Tools to predict the risk of IVIG resistance in eastern China are lacking.In our series, haemoglobin level, percentage of neutrophils, platelet count, coronary artery damage, incomplete Kawasaki disease, and CRP, serum albumin, serum sodium, and serum alkaline phosphatase levels were risk factors of IVIG resistance in hospitalized children in the eastern China cities of Suzhou and Fuzhou.We propose an easy-to-use nomogram to predict the risk factors of IVIG resistance in hospitalized children.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Hongbiao</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Fujian Provincial Hospital, Fujian Provincial Clinical College of Fujian Medical University, Fuzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Jiaqi</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shi</LastName>
            <ForeName>Xiaosong</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Fujian Provincial Hospital, Fujian Provincial Clinical College of Fujian Medical University, Fuzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qin</LastName>
            <ForeName>Jie</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dong</LastName>
            <ForeName>Jinfeng</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Hematology and Rheumatology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Lei</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Chengcheng</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Ying</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zheng</LastName>
            <ForeName>Yiming</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hou</LastName>
            <ForeName>Miao</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shen</LastName>
            <ForeName>Qin</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zeng</LastName>
            <ForeName>Bihe</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qian</LastName>
            <ForeName>Guanghui</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Fang</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Fujian Provincial Hospital, Fujian Provincial Clinical College of Fujian Medical University, Fuzhou, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lv</LastName>
            <ForeName>Haitao</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Institute of Pediatric Research, Children's Hospital of Soochow University, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Ann Med</MedlineTA>
        <NlmUniqueID>8906388</NlmUniqueID>
        <ISSNLinking>0785-3890</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016756" MajorTopicYN="Y">Immunoglobulins, Intravenous</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009080" MajorTopicYN="Y">Mucocutaneous Lymph Node Syndrome</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049451" MajorTopicYN="N">Nomograms</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Kawasaki disease</Keyword>
        <Keyword MajorTopicYN="Y">LASSO regression</Keyword>
        <Keyword MajorTopicYN="Y">intravenous immunoglobulin resistance</Keyword>
        <Keyword MajorTopicYN="Y">nomogram</Keyword>
        <Keyword MajorTopicYN="Y">prediction model</Keyword>
      </KeywordList>
      <CoiStatement>None of the authors declare any competing interest related to this study.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>31</Day>
          <Hour>12</Hour>
          <Minute>14</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35099338</ArticleId>
        <ArticleId IdType="pmc">PMC8812733</ArticleId>
        <ArticleId IdType="doi">10.1080/07853890.2022.2031273</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Lo MS, Newburger JW.. 
Role of intravenous immunoglobulin in the treatment of Kawasaki disease. Int J Rheum Dis. 2018;21(1):64–69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29205910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogata S, Bando Y, Kimura S, et al. . 
The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. J Cardiol. 2009;53(1):15–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19167633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang H, Xu L, Ding Y, et al. . 
Bioinformatics identification of hub genes and signaling pathways regulated by intravenous immunoglobulin treatment in acute Kawasaki disease. Exp Ther Med. 2021;22(1):1–13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8145699</ArticleId>
            <ArticleId IdType="pubmed">34055083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Group J.
Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease. Pediatr Int. 2005;47(6):711–732.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16354233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wright DA, Newburger JW, Baker A, et al. . 
Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr. 1996;128(1):146–149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8551407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ae R, Abrams JY, Maddox RA, et al. . 
Corticosteroids added to initial intravenous immunoglobulin treatment for the prevention of coronary artery abnormalities in high-risk patients with Kawasaki disease. J Am Heart Assoc. 2020;9(17):e015308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7660775</ArticleId>
            <ArticleId IdType="pubmed">32811256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobayashi T, Inoue Y, Takeuchi K, et al. . 
Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113(22):2606–2612.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16735679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Egami K, Muta H, Ishii M, et al. . 
Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr. 2006;149(2):237–240.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16887442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sano T, Kurotobi S, Matsuzaki K, et al. . 
Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr. 2006;166(2):131–137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16896641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sleeper LA, Minich LL, McCrindle BM, Pediatric Heart Network Investigators, et al.. 
Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011;158(5):831–835.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3075321</ArticleId>
            <ArticleId IdType="pubmed">21168857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Son MBF, Gauvreau K, Kim S, et al. . 
Predicting coronary artery aneurysms in Kawasaki disease at a North American center: an assessment of baseline z scores. JAHA. 2017;6(6):e005378.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5669166</ArticleId>
            <ArticleId IdType="pubmed">28566299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang Y, Yan W, Sun L, et al. . 
Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an east China population. Clin Rheumatol. 2016;35(11):2771–2776.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27491972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Newburger JW, Takahashi M, Gerber MA, et al. . 
Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young. American Heart Association. Circulation. 2004;110(17):2747–2771.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15505111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCrindle BW, Rowley AH, Newburger JW, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention, et al.. 
Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American heart association. Circulation. 2017;135(17):e927–e99.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28356445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akagi T, Rose V, Benson LN, et al. . 
Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr. 1992;121(5):689–694.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1432415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedman J, Hastie T, Tibshirani R.. 
Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2929880</ArticleId>
            <ArticleId IdType="pubmed">20808728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H, Zhang L, Liu Z, et al. . 
Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram. Patient Prefer Adherence. 2018;12:1757–1765. Volume</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6136915</ArticleId>
            <ArticleId IdType="pubmed">30237698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu J, Qiu J, Xie E, et al. . 
Predicting in-hospital rupture of type a aortic dissection using random Forest. J Thorac Dis. 2019;11(11):4634–4646.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6940214</ArticleId>
            <ArticleId IdType="pubmed">31903252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kliegman RM, Stanton BM, Geme JS. Growth, development, and behavior. Nelson textbook of pediatrics. 20th ed. Elsevier; 2015. p. 52.</Citation>
        </Reference>
        <Reference>
          <Citation>Okada K, Hara J, Maki I, Osaka Kawasaki Disease Study Group, et al.. 
Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease. Eur J Pediatr. 2009;168(2):181–185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18446365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang S, Song R, Zhang J, et al. . 
Predictive tool for intravenous immunoglobulin resistance of Kawasaki disease in Beijing. Arch Dis Child. 2019;104(3):262–267.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30026252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie T, Wang Y, Fu S, et al. . 
Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease. Pediatr Rheumatol. 2017;15(1):17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5359815</ArticleId>
            <ArticleId IdType="pubmed">28320400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei M, Huang M, Chen S, et al. . 
A multicenter study of intravenous immunoglobulin non-response in Kawasaki disease. Pediatr Cardiol. 2015;36(6):1166–1172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25812827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma K, Vignesh P, Srivastava P, et al. . 
Epigenetics in Kawasaki disease. Front Pediatr. 2021;9:673294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8266996</ArticleId>
            <ArticleId IdType="pubmed">34249810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuan P, Su D, Mandal KD, et al. . 
Outcomes of Kawasaki disease with giant coronary aneurysms: a single-Centre study in southwest China. Cardiol Young. 2020;30(6):834–839.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32508295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, et al. . 
Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease. Paediatr Int Child Health. 2018;38(3):209–212.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29768976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ashouri N, Takahashi M, Dorey F, et al. . 
Risk factors for nonresponse to therapy in Kawasaki disease. J Pediatr. 2008;153(3):365–368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18534243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rigante D, Valentini P, Rizzo D, et al. . 
Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome. Rheumatol Int. 2010;30(6):841–846.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20049445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sato S, Kawashima H, Kashiwagi Y, et al. . 
Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients. Int J Rheum Dis. 2013;16(2):168–172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23773640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hua W, Sun Y, Wang Y, et al. . 
A new model to predict intravenous immunoglobin-resistant Kawasaki disease. Oncotarget. 2017;8(46):80722–80729.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5655234</ArticleId>
            <ArticleId IdType="pubmed">29113339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lalles JP.
Recent advances in intestinal alkaline phosphatase, inflammation, and nutrition. Nutr Rev. 2019;77(10):710–724.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31086953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peters E, Geraci S, Heemskerk S, et al. . 
Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate. Br J Pharmacol. 2015;172(20):4932–4945.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4621995</ArticleId>
            <ArticleId IdType="pubmed">26222228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang T, Liu G, Lin H.. 
A machine learning approach to predict intravenous immunoglobulin resistance in kawasaki disease patients: a study based on a southeast China population. PLoS One. 2020;15(8):e0237321.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7451628</ArticleId>
            <ArticleId IdType="pubmed">32853226</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
